This is not a comprehensive list be any means, just a list of those currently operating within the canadian commercial paradigm, or are publicly pursuing the possibilities opening up under the proposed MMPR. More names will be added over the next year as companies apply for licenses and make public their intentions.
Bedrocan
http://www.bedrocan.nl/
Bedrocan is a dutch company based in northern Holland that currently supplies 4 standardized varieties of medical cannabis to the Office of Medicinal Cannabis, who in turn re-distributes the medicine via pharmacies in Holland.
Their high THC (19%) variety 'Bedrocan' (tm), formerly known as Jack Herer, was bred by a breeder who is a member of the Bedrocan team. Other varieties include Bedrobinol (tm) (a 14% THC variety), Bedica (tm) (an indica based variety @ 14% THC, also high in Myrcene), and Bediol (tm) (a 6% THC, 7.5% CBD variety).
It's public knowledge that the folks involved with Bedrocan produced seeds in Holland legally until 1998 when the dutch government changed the laws and made indoor seed production illegal. The dutch, ever pragmatic, consulted with these folks (and others) when medical marijuana was raised as an issue in the dutch government system in order to see if they could produce a standardized, consistent, quality crop. In contrast to the Canadian government, who upon tendering the original contract to produce marijuana for medical purposes in Canada, required that the producers must have zero experience in growing cannabis. The dutch decided to seek out those with experience- could this be the difference between Bedrocan and Plant Prarie Systems medicine?
Bedrocan was one of 2 producers to operate in Holland producing cannabis for the OMC, and the only entity currently producing cannabis for medical purposes under license in Holland. The other company, the Stichting Institute of Medical Marijuana (SIMM), had their license terminated in 2005 after levels of pesticides reportedly above tolerable limites were found in the medicine- which were said to be from contamination from nearby crops, as they were producing in a light supplemented greenhouse that contained heat louvres on the greenhouse that allowed heat to rise out from the top of the structure, and by corollary apparently allowed pesticides to enter.
Prarie Plant Systems
http://www.prairieplant.com/
Plant Prairie Systems, aka PPS currently holds the only commercial license to produce cannabis in Canada. Based in Saskatoon, Saskatchewan, they have grown a single variety of cannabis for distribution through Health Canada. There's been a great deal about PPS written in the canadian public media, including court cases and rulings about the quality of the product, which in fact spurned the PPL scheme that will end with the DPL (tentatively?) as of March 31st, 2014.
PPS' medicine was originally produced in a secure mine facility, underground in Flin Flon, Manitoba.
From Wikipedia:
I think PPS got a bit of a bad shake with this government contract to produce- they haven't been able to speak publicly about their product due to the contract with HC, and have also been bound by the requirements for the product as outlined by HC. I feel they can probably produce better medicine than that which we can currently source from them, we'll see if they participate in the new system- I don't see why they wouldn't.
Abbattis Bioceuticals
http://www.abattis.com/s/home.asp
From a recent press release:
Mar 12, 2013
Clearly Abbattis is interested in the market developing out of the MMPR, and sponsoring the AHP Monograph is an attempt to gain media attention and promote their intentions, at least how I see it.
So there's your primer on a few of the players, know who you are 'competing' against.
More to follow....
-Chimera
Bedrocan
http://www.bedrocan.nl/
Bedrocan is a dutch company based in northern Holland that currently supplies 4 standardized varieties of medical cannabis to the Office of Medicinal Cannabis, who in turn re-distributes the medicine via pharmacies in Holland.
Their high THC (19%) variety 'Bedrocan' (tm), formerly known as Jack Herer, was bred by a breeder who is a member of the Bedrocan team. Other varieties include Bedrobinol (tm) (a 14% THC variety), Bedica (tm) (an indica based variety @ 14% THC, also high in Myrcene), and Bediol (tm) (a 6% THC, 7.5% CBD variety).
It's public knowledge that the folks involved with Bedrocan produced seeds in Holland legally until 1998 when the dutch government changed the laws and made indoor seed production illegal. The dutch, ever pragmatic, consulted with these folks (and others) when medical marijuana was raised as an issue in the dutch government system in order to see if they could produce a standardized, consistent, quality crop. In contrast to the Canadian government, who upon tendering the original contract to produce marijuana for medical purposes in Canada, required that the producers must have zero experience in growing cannabis. The dutch decided to seek out those with experience- could this be the difference between Bedrocan and Plant Prarie Systems medicine?
Bedrocan was one of 2 producers to operate in Holland producing cannabis for the OMC, and the only entity currently producing cannabis for medical purposes under license in Holland. The other company, the Stichting Institute of Medical Marijuana (SIMM), had their license terminated in 2005 after levels of pesticides reportedly above tolerable limites were found in the medicine- which were said to be from contamination from nearby crops, as they were producing in a light supplemented greenhouse that contained heat louvres on the greenhouse that allowed heat to rise out from the top of the structure, and by corollary apparently allowed pesticides to enter.
Prarie Plant Systems
http://www.prairieplant.com/
Plant Prairie Systems, aka PPS currently holds the only commercial license to produce cannabis in Canada. Based in Saskatoon, Saskatchewan, they have grown a single variety of cannabis for distribution through Health Canada. There's been a great deal about PPS written in the canadian public media, including court cases and rulings about the quality of the product, which in fact spurned the PPL scheme that will end with the DPL (tentatively?) as of March 31st, 2014.
PPS' medicine was originally produced in a secure mine facility, underground in Flin Flon, Manitoba.
From Wikipedia:
I think PPS got a bit of a bad shake with this government contract to produce- they haven't been able to speak publicly about their product due to the contract with HC, and have also been bound by the requirements for the product as outlined by HC. I feel they can probably produce better medicine than that which we can currently source from them, we'll see if they participate in the new system- I don't see why they wouldn't.
Abbattis Bioceuticals
http://www.abattis.com/s/home.asp
From a recent press release:
Mar 12, 2013
Clearly Abbattis is interested in the market developing out of the MMPR, and sponsoring the AHP Monograph is an attempt to gain media attention and promote their intentions, at least how I see it.
So there's your primer on a few of the players, know who you are 'competing' against.
More to follow....
-Chimera
Last edited:
